Immunome
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunome and other ETFs, options, and stocks.About IMNM
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas.
CEOClay B. Siegall
CEOClay B. Siegall
Employees118
Employees118
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2006
Founded2006
Employees118
Employees118
IMNM Key Statistics
Market cap1.81B
Market cap1.81B
Price-Earnings ratio-6.68
Price-Earnings ratio-6.68
Dividend yield—
Dividend yield—
Average volume1.11M
Average volume1.11M
High today$20.46
High today$20.46
Low today$19.60
Low today$19.60
Open price$20.08
Open price$20.08
Volume782.38K
Volume782.38K
52 Week high$20.46
52 Week high$20.46
52 Week low$5.15
52 Week low$5.15
Stock Snapshot
With a market cap of 1.81B, Immunome(IMNM) trades at $19.60. The stock has a price-to-earnings ratio of -6.68.
During the trading session on 2025-12-07, Immunome(IMNM) shares reached a daily high of $20.46 and a low of $19.60. At a current price of $19.60, the stock is 0.0% higher than the low and still -4.2% under the high.
Trading volume for Immunome(IMNM) stock has reached 782.38K, versus its average volume of 1.11M.
The stock's 52-week range extends from a low of $5.15 to a high of $20.46.
The stock's 52-week range extends from a low of $5.15 to a high of $20.46.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMNM. This list is generated using Robinhood data, and it’s not a recommendation.